The HCPLive age-related macular degeneration condition center page is a comprehensive resource for clinical news and insights on retina disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for patients with AMD.
May 13th 2024
At the end of ARVO 2024, Srinivas R. Sadda, MD, became the organization's president for the 2024-2025 year. He spoke to HCPLive about his expectations for the next year in eye care.
Phase 4 Trial Reports Positive Data on Teprotumumab for Thyroid Eye Disease
April 10th 2023Announced today by Horizon Therapeutics, the positive and statistically significant data supports the efficacy of teprotumumab across a spectrum of patients with TED regardless of disease activity or duration.
Long-Term Efficacy of Aflibercept, Ranibizumab Consistent in Eyes with Wet AMD
April 6th 2023After a two-year intensive therapy period, visual acuity was maintained or improved in nearly half of the ranibizumab-treated group and more than half of the aflibercept-treated group, but severely declined during the post-intensive period.
Longer Time Between Diabetic Retinopathy Examinations May Be Viable for IHS Patients
March 10th 2023Estimates of DR incidence and progression were lower than previously reported for American Indian and Alaska Native individuals served by the Indian Health Service, suggesting the potential for longer intervals between evaluations.
Charles Wykoff, MD, PhD: Significance of the Pegcetacoplan Approval for GA
February 22nd 2023The historic FDA approval of pegcetacoplan marks the first and only approved treatment for geographic atrophy. In a new interview, Dr. Wykoff expresses what approval means for patients with the debilitating disease.